2018
DOI: 10.1371/journal.pone.0209611
|View full text |Cite
|
Sign up to set email alerts
|

Genome-wide maps of distal gene regulatory enhancers active in the human placenta

Abstract: Placental dysfunction is implicated in many pregnancy complications, including preeclampsia and preterm birth (PTB). While both these syndromes are influenced by environmental risk factors, they also have a substantial genetic component that is not well understood. Precisely controlled gene expression during development is crucial to proper placental function and often mediated through gene regulatory enhancers. However, we lack accurate maps of placental enhancer activity due to the challenges of assaying the… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 32 publications
0
5
0
Order By: Relevance
“…Similarly, GFI1 plays a crucial role during embryogenesis of other tissues [ 33 ]. During embryogenesis the enhancers’ network is one of the expanded regulatory networks and often incorporates Transposable Elements (TE) including Alus , which later become repressed [ 34 36 ]. Currently, GeneHancer resource provides evidence (eQTL only) for the target region as an enhancer of GFI1 [ 11 ].…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, GFI1 plays a crucial role during embryogenesis of other tissues [ 33 ]. During embryogenesis the enhancers’ network is one of the expanded regulatory networks and often incorporates Transposable Elements (TE) including Alus , which later become repressed [ 34 36 ]. Currently, GeneHancer resource provides evidence (eQTL only) for the target region as an enhancer of GFI1 [ 11 ].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the identification of active enhancers in placental tissue is extremely crucial. Here we designed an experiment for 4,562 placental enhancers [ 59 ] and then compared the experimental results of SMFM with other existing enhancer methods. To conduct a fair experiment in the placental enhancers task, we did not perform targeted parameter tuning for all methods used for comparison.…”
Section: Resultsmentioning
confidence: 99%
“…Concerning preterm birth, studies focus on cervix-related risk [ 102 , 103 ], classifying true preterm labor [ 104 , 105 ], determining neonate mortality and prognosis [ 106 , 107 ], predicting preterm birth risk [ 108–111 ], professional learning [ 112 ], estimating postnatal gestational age [ 113 ] and improving knowledge of gene regulatory elements in the placenta [ 114 ]. In 1982, Grignolio [ 106 ] presented a method to predict neonate mortality of premature newborns, using multiple regression.…”
Section: Discussionmentioning
confidence: 99%
“…Perinatal outcome was predicted with a DL model interpreting amniotic fluid metabolomics and proteomics in asymptomatic pregnant women with short CL [ 109 ]. SVM was applied to predict genome-wide placental enhancers, in order to further the understanding of placental dysfunction and implications of preterm birth and preeclampsia [ 114 ].…”
Section: Discussionmentioning
confidence: 99%